| # | Side effect | Count |
|---|---|---|
| 0 | NO ADVERSE EVENT | 304 |
| 1 | PRODUCT DOSE OMISSION | 178 |
| 2 | PRODUCT AVAILABILITY ISSUE | 168 |
| 3 | BLADDER CANCER RECURRENT | 131 |
| 4 | PYREXIA | 73 |
| 5 | DRUG DOSE OMISSION | 66 |
| 6 | DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION | 58 |
| 7 | DRUG INEFFECTIVE | 52 |
| 8 | PRODUCT DOSE OMISSION ISSUE | 50 |
| 9 | PRODUCT SUPPLY ISSUE | 42 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | BLADDER GRANULOMA | 4 | 0.3333 |
| 1 | BLADDER CANCER RECURRENT | 131 | 0.1765 |
| 2 | BLADDER DYSPLASIA | 2 | 0.1667 |
| 3 | DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION | 58 | 0.1620 |
| 4 | RADICAL CYSTECTOMY | 4 | 0.1538 |
| 5 | EPIDIDYMITIS TUBERCULOUS | 4 | 0.1176 |
| 6 | SECONDARY TRANSMISSION | 2 | 0.1000 |
| 7 | TRANSITIONAL CELL CARCINOMA RECURRENT | 2 | 0.0909 |
| 8 | EXPOSURE TO BODY FLUID | 2 | 0.0769 |
| 9 | BOVINE TUBERCULOSIS | 28 | 0.0765 |